Search concepts
|
Selected Filters
|
- 1 - 50 out of 1,428 results
Search results
-
An Open-Label Randomized Active-Controlled Phase II Clinical Study to Assess the Efficacy and Safety of Afuresertib Plus Paclitaxel Versus Paclitaxel in Patients with Platinum-ResistantOvarian Cancer
Kamat, A. A., Alaniz, A., Darcourt, J., Singh, M., Suri, A. & Zaid, T.
3/15/21 → 3/14/46
Project: Non Profit
-
-
A Pilot Randomized Controlled Trial of De Novo Belatacept-Based Immunosuppression in Lung Transplantation
3/26/20 → 3/25/45
Project: Non Profit
-
CTSU - IRB SUBMISSIONA Phase III Trial To Evaluate The Efficacy Of The Addition Of Inotuzumab Ozogamicin (A Conjugated Anti-Cd22 Monoclonal Antibody) To Frontline Therapy In Young Adults (Ages 18-39 Years) With Newly Diagnosed Precursor B-Cell ALL.
Abdelrahim, M., Bernicker, E. H., Chang, J. C., Heyne, K., Niravath, P. A., Singh, M. & Zhang, J.
3/6/20 → 3/5/45
Project: Non Profit
-
INTEGRATION OF IMMUNOTHERAPY INTO ADJUVANT THERAPY FOR RESECTED NSCLC: ALCHEMIST CHEMO-IO (ACCIO)
Bernicker, E. H. & Zhang, J.
3/6/20 → 3/5/45
Project: Non Profit
-
ALLIANCE A221602: OLANZAPINEWITH ORWITHOUT FOSAPREPITANT FOR THE PREVENTION OF CHEMOTHERAPY INDUCED NAUSEA AND VOMITING (CINV) IN PATIENTS RECEIVING HIGHLY EMETOGENIC CHEMOTHERAPY (HEC): A PHASE III RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
Darcourt, J., Bernicker, E. H., Chang, J. C., Geyer, C. E., Heyne, K. & Niravath, P. A.
3/6/20 → 3/5/45
Project: Non Profit
-
EA5163/S1709 INSIGNA: A Randomized, Phase III Study of Firstline Immunotherapy alone or in Combination with Chemotherapy in Induction/Maintenance or Postprogression in Advanced Nonsquamous Non¿Small Cell Lung Cancer (NSCLC) with Immunobiomarker SIGNature
Bernicker, E. H., Darcourt, J. & Zhang, J.
2/28/19 → 2/27/44
Project: Non Profit
-
Prevention of De Novo HCV with Antiviral HCV Therapy Post-Liver and Post-Kidney Transplant
9/18/18 → 9/17/43
Project: Non Profit
-
A phase III, multicenter, randomized, study of atezolizumab/placebo administered in combination with paclitaxel, carboplatin, and bevacizumab to patients with newly-diagnosed stage III or stage IV ovarian, fallopian tube, or primary peritoneal cancer
Kamat, A. A., Alaniz, A., Bernicker, E. H., Darcourt, J., Heyne, K., Singh, M., Suri, A. & Zaid, T.
3/13/18 → 3/12/43
Project: Non Profit
-
PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO- CONTROLLED, PARALLEL-GROUP, STUDY OF AB103 AS COMPARED TO PLACEBO IN PATIENTS WITH NECROTIZING SOFT TISSUE INFECTIONS (NSTI)
Dhala, A., Martinez, S., Mobley, C. M. & Ochoa, R. A.
6/20/17 → 6/19/42
Project: Federal Funding Agencies
-
A RANDOMIZED PHASE III DOUBLE BLINDED PLACEBO CONTROLLED TRIAL OFASPIRIN AS ADJUVANT THERAPY FOR HER2 NEGATIVE BREAST CANCER: THE ABCTRIAL
Arentz, C., Abdelrahim, M., Bernicker, E. H., Chang, J. C., Heyne, K., Niravath, P. A., Singh, M. & Zhang, J.
12/8/16 → 12/7/41
Project: Non Profit
-
EAY131 - Molecular Analysis for Therapy Choice (MATCH)
Bernicker, E. H., Chang, J. C., Darcourt, J., Heyne, K., Kamat, A. A., Pingali, S. R. & Singh, M.
9/20/16 → 9/20/41
Project: Federal Funding Agencies
-
-
A Randomized, Phase II/III Study of Pegylated Liposomal Doxorubicin and CTEP-Supplied Atezolizumab (IND #134427) Versus Pegylated Liposomal Doxorubicin/Bevacizumab and CTEP-Supplied Atezolizumab Versus Pegylated Liposomal Doxorubicin/Bevacizumab in P
Kamat, A. A., Darcourt, J., Singh, M., Suri, A. & Zaid, T.
3/1/14 → 2/28/39
Project: Non Profit
-
Colorectal Cancer Metastatic dMMR Immuno-Therapy (COMMIT) Study:A Randomized Phase III Study of mFOLFOX6/Bevacizumab Combination Chemotherapy with orwithout Atezolizumab or Atezolizumab Monotherapy in the First-Line Treatment of Patients withDefici
Abdelrahim, M., Bernicker, E. H., Darcourt, J., Heyne, K. & Singh, M.
3/1/14 → 2/28/39
Project: Non Profit
-
A Randomized Phase II Trial of Radiation Therapy and Cisplatin Alone or in Combination withIntravenous Triapine in Women with Newly Diagnosed Bulky Stage IB2, Stage II, IIIB, or IVACancer of the Uterine Cervix or Stage II-IVA Vaginal Cancer.
Zaid, T., Butler, E. B., Darcourt, J., Farach, A. M., Kamat, A. A., Shkedy, C., Singh, M. & Suri, A.
3/1/14 → 2/28/39
Project: Non Profit
-
RTOG-0834; RTOG-0913; RTOG-0929
Radiation Therapy Oncology Group
8/10/11 → 12/25/38
Project: Federal Funding Agencies
-
-
PHASE III RANDOMIZED STUDY OF SORAFENIB PLUS DOXORUBICIN VERSUS SORAFENIB IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA (HCC)
Bernicker, E. H., Darcourt, J. & Singh, M.
8/13/13 → 8/12/38
Project: Non Profit
-
-
-
A Phase II/III Trial of Neoadjuvant FOLFOX w/ Selective Use of Combined Modality Chemoradiation versus Preoperative Combined Modality Chemoradiation for Locally Advanced Rectal Cancer Patients Undergoing Low Anterior Resection w/ Total Mesorectal Excisio
Bernicker, E. H., Darcourt, J. & Singh, M.
6/11/13 → 6/10/38
Project: Non Profit
-
Escalating Clopidogrel by Involving a Genetic Strategy (ELEVATE-TIMI 56)
11/10/10 → 3/27/38
Project: Non Profit
-
TrialNet Natural History Study of the Development of Type 1 Diabetes
9/13/10 → 1/28/38
Project: Federal Funding Agencies
-
Prospective multi-center randomized double-blind trial to assess the effectiveness and safety of 12 vs 30 months of dual antiplatelet therapy (DAPT) in subjects undergoing percutaneous coronary intervention (PCI) with either drug-eluting (DES) or bar
Harvard Clinical Research Institute
6/30/10 → 11/14/37
Project: Non Profit
-
Gaining Efficacy Long Term:Hydrosoft and Emerging New Embolic Coil (Gel-the-nec)
1/18/10 → 6/4/37
Project: Non Profit
-
A Randomized Double-Blind Placebo-Controlled Biomarker Modulation Study of Vitamin D in premenopausal Women at High Risk for Breast Cancer, Phase IIB
6/29/12 → 3/22/37
Project: Federal Funding Agencies
-
4/4-American Consortium of Early Liver Transplantation-Prospective Alcohol-associated liver disease Cohort Evaluation (ACCELERATE-PACE)
8/1/23 → 7/31/30
Project: Federal Funding Agencies
-
Daratumab to Enhance therapeutic Effectiveness of Revlimid in Smoldering Myeloma (DETER-SMM)
4/30/19 → 4/29/29
Project: Non Profit
-
Tumor-specific CD8+ Tc9 cells activate host CD4+ T cells to control antigen-lost tumors
1/1/24 → 12/31/28
Project: Federal Funding Agencies
-
-
Spinal Neuromodulation to Promote Physiologic and Molecular Plasticity in the Injured Spinal Cord
9/20/23 → 8/31/28
Project: Federal Funding Agencies